# The Use of Oral Naloxone to Prevent Post Spinal Fusion Ileus

> **NCT03176316** · PHASE4 · TERMINATED · sponsor: **Loyola University** · enrollment: 53 (actual)

## Conditions studied

- Ileus
- Fusion of Spine

## Interventions

- **DRUG:** Naloxone

## Key facts

- **NCT ID:** NCT03176316
- **Lead sponsor:** Loyola University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-09-20
- **Primary completion:** 2020-02-20
- **Final completion:** 2020-02-20
- **Target enrollment:** 53 (ACTUAL)
- **Why stopped:** The study was terminated by the Institutional Review Board.
- **Last updated:** 2024-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03176316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03176316, "The Use of Oral Naloxone to Prevent Post Spinal Fusion Ileus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03176316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*